Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0012 USD | 0.00% |
|
0.00% | -75.51% |
02-01 | Innovation Pharmaceuticals Inc. Announces Resignation of Board Members | CI |
2023 | Alfasigma S.p.A. and Innovation Pharmaceuticals Inc. Terminate Exclusive License Agreement | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
Jane Harness
CTO | Chief Tech/Sci/R&D Officer | 55 | 16-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leo Ehrlich
CEO | Chief Executive Officer | 66 | 07-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 6,692,473 | 0 | 2,358,537 ( 35.24 %) | 87.87 % |
Stock B | 1 | 522,529,811 | 465,030,028 ( 89.00 %) | 8,516,056 ( 1.630 %) |
Company contact information
Innovation Pharmaceuticals, Inc.
301 Edgewater Place Suite 100
01880, Wakefield
+
http://www.ipharminc.com![address Innovation Pharmaceuticals Inc.(IPIX)](https://cdn.zonebourse.com/static/address/111313705.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-75.51% | 635K | |
+15.20% | 122B | |
+19.67% | 113B | |
+18.95% | 26.49B | |
-23.86% | 19.4B | |
-19.03% | 16.24B | |
-20.90% | 15.4B | |
-46.14% | 15.15B | |
+63.85% | 14.93B | |
+4.49% | 13.52B |
- Stock Market
- Equities
- IPIX Stock
- Company Innovation Pharmaceuticals Inc.